Search

Search results

99 results found

Premier Clinical Care

Education, Research, and Reflection for Unrivaled Clinical Care Harvard Ophthalmology continues to forge a future without blindness. With landmark breakthroughs in antiVEGF therapies, surgical techniques, ocular imaging, laser surgery, pro-regenerative therapies, and gene therapy, the department’s...

FAQ

PDF of this FAQ Q: Can I get guidance on writing the pre-proposal? A: Yes, we encourage you to contact us, so that we can help you draft a milestone-based research plan with go/no-go decision points. Please contact the Senior Director, Translational Research at ifat_rubin-bejerano@hms.harvard.edu. Q...

Eye Witness 39 - Jan 2020

DOWNLOAD FULL ISSUE Groundbreaking Research Achievements In honor of the year 2020, Harvard Ophthalmology is reflecting on past accomplishments and celebrating our ongoing commitment to alleviate the burden of blindness. This issue focuses on our groundbreaking research. Transformational Research to...

About DCI

Founded in 1970 by Drs. Howard Bleich and Dr. Warner Slack, DCI was among the first academic divisions in the world to concentrate on the use of computers for patient care, teaching, and medical research. The goals of DCI have been to improve the quality and reduce the cost of medical care, to...

Internships at DCI

2021 Pharmacy Clinical Informatics Summer Internship Program The goal of the Pharmacy Clinical Informatics Summer Internship Program is to develop future pharmacy leaders in informatics through exposure to population health and clinical informatics principles through concepts such as data model...

Exosomes as Extracellular Mediators of Cancer

We gained new insight into the potential for some types of extracellular RNA called microRNA (miRNA) to influence cancer progression ( Cancer Cell 2014 ). The research suggests that cancer cell exosomes, vesicles that are secreted by cells and present in many biological fluids, and the associated...

Message from the Editor-in-Chief

Dear Colleagues, In this issue of eye Insights, we highlight two treatments for the management of strabismus: botulinum toxin and adjustable sutures. We include indications for their use, techniques to incorporate them into practice, and outcomes. A list of peer-reviewed journal articles is included...

Treatment Option: Botulinum Toxin

Botulinum toxin (BT) for the management of strabismus was approved by the FDA in 1989 based on work by pediatric ophthalmologist Alan B. Scott, MD. BT can be the first-line treatment for certain forms of strabismus. Indications Acute comitant esotropia in children: BT can be injected to both medial...

Treatment Option: Adjustable Sutures

Standard strabismus surgery involves altering the position or length of the extraocular muscles to improve ocular alignment. The muscle is reattached to the globe at a set position. The adjustable suture technique was introduced to refine the result immediately after surgery in both adults and...